Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to test the hypothesis that switching to exenatide and metformin is non-inferior to adding exenatide to sitagliptin and metformin, as measured by a change in HbA1c from baseline to endpoint (Week 16), in patients with type 2 diabetes experiencing inadequate glycemic control with sitagliptin plus metformin.
Critère d'inclusion
- Diabetes Mellitus, Type 2